Penile traction devices
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Penile traction devices (PTDs) are non‑surgical tools used mainly to treat Peyronie’s disease (PD) and to limit length loss or erectile dysfunction after prostate surgery; randomized and meta‑analytic evidence shows modest but measurable gains — typically around 0.8–2.0 cm in stretched penile length and curvature reductions of roughly one‑third in many studies [1] [2] [3]. Newer, clinic‑backed devices such as RestoreX report clinically significant improvements with much shorter daily wear (30–90 minutes) in early trials, but most prior studies required hours per day and had variable protocols and durations [4] [5] [1].
1. What these devices are and how they’re supposed to work
Penile traction devices generally consist of a cradle or support ring, a silicone band and adjustable rods that apply a gentle, continuous tensile force to the penis; the intended biological effect is gradual remodeling of the tunica albuginea to reduce curvature and length loss [1] [2]. Manufacturers and clinical teams describe a progressive increase in extension by adding rod lengths over weeks while patients wear the device for prescribed hours per day [1].
2. Evidence for benefit — short gains, meaningful for some patients
Systematic reviews and trials report consistent but modest length gains and curvature improvement for men with Peyronie’s disease: meta‑analyses show PTT can increase stretched penile length and improve erectile function and curvature versus no treatment [2] [1]. Individual devices report different magnitudes: industry and summary sources cite length gains in the range of about 1.8–2.4 cm and curvature reductions around 33–35% in some analyses [3], while early randomized data and prior reports documented average gains near 0.8 cm with longer daily wear [1] [4].
3. Newer trials, shorter daily wear — promising but preliminary
Researchers at the Mayo Clinic and other groups have published early trial data showing a device (RestoreX) achieving statistically significant improvements in length and curvature with only 30–90 minutes of daily use over three months; investigators described surprise because earlier studies typically required 3–6 hours daily [4] [5]. A December 2025 randomized controlled trial focusing on post‑prostatectomy patients also appears in the literature stream, indicating ongoing clinical evaluation across indications [6].
4. Which devices and indications researchers mention
Reviews and clinical summaries list several commercial PTDs — e.g., Penimaster PRO, Andropenis/Andropeyronie, RestoreX, SizeGenetics, Quick Extender Pro — and note most evidence centers on PD or post‑radical prostatectomy length preservation, while vacuum devices are preferentially studied for erectile dysfunction after prostatectomy [7] [1] [8]. Device‑specific claims (e.g., RestoreX curve improvement in 77% of men or specific inch‑range fits) appear in manufacturer or clinic pages and store descriptions [5] [8].
5. Practical tradeoffs: time, patience and tolerance
Historically, many studies required prolonged daily wear (several hours) over months to achieve effects; that creates adherence challenges and potential for minor side effects such as skin irritation or discomfort [1] [2]. Newer devices advertise shorter required wear times, which could improve uptake, but shorter‑wear findings are limited to a smaller set of trials and need broader replication [4] [5].
6. Conflicting claims and commercial messaging to watch for
Commercial and review sites sometimes report larger gains (up to 1.5 inches or consistent 1.8–2.4 cm) and high percentages of curvature correction; these numbers derive from selective studies, device registries, or manufacturer summaries rather than a uniform body of high‑quality RCTs [3] [9] [5]. Independent systematic reviews temper enthusiasm by describing modest average improvements and variable study quality [2] [1].
7. What clinicians and guideline‑level summaries say
Clinical reviews and comparative summaries suggest traction devices are a reasonable non‑invasive option for PD and for length preservation after prostatectomy and may outperform vacuum therapy for curvature; however, evidence varies by device and indication and research favors certain models (e.g., Penimaster Pro, RestoreX) in reported outcomes [7] [2].
8. Limitations in the record and what’s not in current reporting
Available sources do not mention long‑term durability beyond most study follow‑ups, broad head‑to‑head RCTs across many devices, nor independent large‑scale safety registries comparing devices (not found in current reporting). Several marketed claims originate from manufacturers or clinic stores rather than independent trials [5] [8].
Bottom line: PTDs offer a non‑surgical, evidence‑backed option that gives modest penile length gains and curvature improvement for many men with Peyronie’s disease or after prostate surgery; device choice, daily wear time and realistic expectations should be discussed with a urologist, and newer short‑wear protocols look promising but require broader independent confirmation [2] [4] [7].